Services - CRO/CMO/CDMO

Avista Healthcare Partners, a US-based healthcare-focused private equity firm, and Damier Group, the Belgium-based family office of Yvan Vindevogel, have signed a definitive agreement...

Adragos Pharma, a Germany-based global CDMO, has appointed Konstantinos (Kostas) Rengis as its new CEO, succeeding company founder and CEO for the last six...

Lauxera Capital Partners has closed its second growth fund at €520m (US$605m), surpassing its €500m hard cap and nearly doubling the size of its...

Cheplapharm, a family-run pharmaceutical company headquartered in Germany, specialising in the development, marketing, and distribution of branded pharmaceutical products, is aligning its management board for the company’s next...

Water Street Healthcare Partners has held the first and final close of its sixth private equity fund at US$1.9bn. Fund VI was oversubscribed and...

Dirk Scholz has taken up his new role as CFO of the Sanner Group, a Germany-based global healthcare packaging and medical device CDMO. He succeeds...

CordenPharma, a Swiss-based full-service CDMO of APIs, lipid excipients, drug products and packaging, has appointed Marc Augustin as CFO. Augustin joins from PolyPeptide where he...

Columna Capital has acquired a majority stake in Evidenze Group, a Spain‑based full‑service CRO, from Buenavista Equity Partners. The UK‑based pan‑European lower mid‑market investor...

Panthera Biopartners (Panthera), the LDC-backed UK based clinical trial Site Management Organisation (SMO), has announced the acquisition of Óbudai Egészségügyi Centrum Kft (OEC), a...

Alcami Corporation, a US-based CDMO, is acquiring Tjoapack, a Netherlands-based global contract packaging organisation (CPO) serving the pharmaceutical and biotech industries. Ampersand Capital Partners...